Qualcomm's AI Leap: A New Era of Growth and Value

by : Suze Orman
Qualcomm is embarking on a transformative journey, strategically pivoting towards artificial intelligence. Despite past stock market hesitations, the company's recent Investor Day unveiled a robust growth strategy, positioning it as a formidable contender in the evolving AI landscape.

Unlocking the Future: Qualcomm's Visionary Path in AI and Beyond

Qualcomm's Strategic Shift Towards AI Dominance

Qualcomm, a leader in wireless technology, has made a significant commitment to the artificial intelligence chip sector. This strategic move is not just a modest expansion but a profound reorientation of its business model, aiming to capitalize on the burgeoning demand for AI-driven solutions across various industries.

Ambitious Financial Targets: Non-Handset Revenue Projections

The company has set ambitious financial targets, projecting its non-handset revenue to exceed $40 billion by fiscal year 2029. This forecast highlights a deliberate diversification away from its traditional mobile-centric revenue streams, indicating a future where AI and other advanced technologies play a dominant role.

Data Center and Automotive: Key Drivers of Future Growth

A substantial portion of this projected growth is expected to come from data center contracts with hyperscalers, alongside a significant increase in its automotive segment guidance to over $10 billion. These areas represent strategic strongholds where Qualcomm anticipates leveraging its technological prowess to capture considerable market share.

Long-Term Vision: EPS and Total Revenue Growth

Management's long-term vision extends to achieving an Earnings Per Share (EPS) above $18 by fiscal year 2029, with an overarching goal of scaling total revenue towards $100 billion. This aggressive outlook is underpinned by a commitment to maintaining robust free cash flow and ensuring flexibility in capital returns to shareholders.

Market Valuation and AI-Driven Upside

Despite these promising projections, Qualcomm's stock, currently trading around $200 per share, appears undervalued relative to its fiscal year 2029 EPS targets. This suggests a significant AI-driven upside that has yet to be fully recognized by the market, presenting a compelling opportunity for investors.

Rivian: A Potential Game-Changer in the EV and Robotaxi Markets
by : Michele Ferrero
Rivian: A Potential Game-Changer in the EV and Robotaxi Markets
Rivian is positioning itself to replicate Tesla's growth trajectory by strategically entering the electric vehicle (EV) and nascent robotaxi markets. With its recent introduction of more affordable models and a substantial order from Uber Technologies for its R2 SUVs, Rivian demonstrates a clear path toward market expansion and innovation in autonomous driving. Despite being undervalued compared to Tesla, its aggressive moves into the AI-driven robotaxi sector offer significant long-term potential for investors.
learn more
STMicroelectronics: Navigating AI Transformation and Market Dynamics
by : Mariana Mazzucato
STMicroelectronics: Navigating AI Transformation and Market Dynamics
STMicroelectronics is actively transitioning into a significant player in AI infrastructure and Low Earth Orbit (LEO) satellite markets, as evidenced by a 23% year-over-year revenue increase in Q1. The company projects its data center revenue to reach $1 billion by 2026, potentially doubling to $2 billion by 2027, driven by strong collaborations with AWS and emerging LEO opportunities. However, gross margin recovery lags, with Q1 non-GAAP gross margin at 34.1%, falling short of the 44–46% target by 2027/2028. Despite this, the stock's recent appreciation already reflects much of its near-term upside, leading to a "Hold" rating with a $78 price target.
learn more
Eagle Point Credit: Prioritizing Senior Securities Over Common Stock
by : Robert Kiyosaki
Eagle Point Credit: Prioritizing Senior Securities Over Common Stock
Eagle Point Credit (ECC) specializes in CLO equity and junior debt, which offers high yields but comes with significant risk, especially for common shareholders. The company's net investment income is currently under pressure due to realized and unrealized losses, with only a small fraction per share allocated to common shareholders in Q1. The asset coverage ratio for preferred stock recently dropped below the 200% threshold, leading ECC to repurchase notes to regain compliance. Given the erosion of NAV, dividend cuts, and ongoing risks, I recommend favoring ECC's preferred shares (ECC.PR.D) and debt over its common stock.
learn more
Albemarle: Riding the Energy Storage Wave
by : Suze Orman
Albemarle Corporation is experiencing a resurgence driven by the escalating demand for lithium in energy storage systems (ESS). Despite a dip in EV sales, ESS has become a primary growth engine, significantly boosting the company's financial performance. This shift highlights the critical role of lithium in diverse energy sectors beyond electric vehicles, positioning Albemarle for substantial future growth as lithium prices continue to recover.
Cybin: A Speculative Bet on Their Pivotal Depression Readout
by : David Rubenstein
Cybin Inc., operating as Helus Pharma, is a clinical-stage neuropsychiatry company focused on developing deuterated serotonergic therapies for mood and anxiety disorders. The company's primary value driver is HLP003, with pivotal Phase 3 APPROACH trial data expected in Q4 2026. Helus Pharma recently secured significant funding, ensuring sufficient resources to reach this milestone, and also holds promising optionality with HLP004 for Generalized Anxiety Disorder, balancing typical biotech risks.
Alphabet's Strategic Moves: AI Integration and Regulatory Challenges
by : Dave Ramsey
Alphabet Inc. (GOOG) has recently expanded its partnership with Nokia, integrating Google's Gemini AI models into Nokia's network software to enhance telecommunication issue resolution and reduce operational costs. Concurrently, the company faces scrutiny from Britain's competition watchdog regarding the transparency of its search ranking algorithms, pushing for objective criteria and clearer complaint processes to ensure fair competition. These developments highlight Alphabet's dual focus on technological advancement and navigating increasing regulatory demands.
Boston Scientific: A Deeper Look into its Market Standing and Future Prospects
by : Dave Ramsey
Boston Scientific (BSX) is being evaluated as a top low-volatility stock under $50, despite recent price target adjustments by financial analysts. This article delves into the reasons behind these revised outlooks, including changing market conditions, and highlights the company's diverse medical device portfolio.